Late-Onset Sepsis Reduced in Premature Infants Fed Prolacta’s 100% Human Milk-Based Fortifiers as Part of an Exclusive Human Milk Diet
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Late-Onset Sepsis
Why Human Milk Plays an Essential Role in Preemie Development
Type: Prolacta in the News
Topic(s): Late-Onset Sepsis Necrotizing Entercolitis (NEC)
Understanding neonatal sepsis
Type: Blog
Topic(s): Late-Onset Sepsis Parents
Economic Benefits and Costs of Human Milk Feedings | Latch
Type: Blog
Topic(s): Bronchopulmonary Dysplasia (BPD) Late-Onset Sepsis Necrotizing Entercolitis (NEC) Neurodevelopmental Outcomes
Prolacta Bioscience Supports Prematurity Awareness Month with New Educational Resources for Parents of Preemies
Type: Press Releases
Topic(s): Late-Onset Sepsis Necrotizing Entercolitis (NEC)
Interview: The Benefits of Early Enteral Feeding
Type: Prolacta in the News
Topic(s): Feeding Protocols Late-Onset Sepsis Necrotizing Entercolitis (NEC)
Prolacta Bioscience Brings Together International Experts for Human-Milk Symposium
Type: Press Releases
Topic(s): Conferences and Events Late-Onset Sepsis Necrotizing Entercolitis (NEC)
New Scientific Report Supports the Use of Prolacta’s Neonatal Nutritional Products in Extremely Premature Infants
Type: Press Releases
Topic(s): Clinical Studies Late-Onset Sepsis Necrotizing Entercolitis (NEC)
Not finding the reference you’re looking for?
Email us at info@prolacta.com
